About Congenital neutropenia-combined immunodeficiency due to MKL1 deficiency
Congenital neutropenia-combined immunodeficiency due to MKL1 deficiency is a rare disease catalogued by Orphanet (ORPHA:619941). It is associated with the MRTFA gene. Search below for active recruiting clinical trials from ClinicalTrials.gov, or visit the Orphanet expert page for specialist centres, natural history studies, and patient registries.
Clinical Trial Eligibility Tips
What to know before applying to Congenital neutropenia-combined immunodeficiency due to MKL1 deficiency trials.
Search ClinicalTrials.gov for "Congenital neutropenia-combined immunodeficiency due to MKL1 deficiency" or filter by Orphanet code ORPHA:619941 to find disease-specific studies.
Ask your specialist to refer you to a Centre of Expertise — Orphanet lists all accredited centres for this condition worldwide.
Natural history studies and patient registries often enrol before drug trials open — contact the Orphanet patient community first.
Patient Resources
Find recruiting Congenital neutropenia-combined immunodeficiency due to MKL1 deficiency trials
Search 500,000+ studies from ClinicalTrials.gov, filtered for Congenital neutropenia-combined immunodeficiency due to MKL1 deficiency. Updated daily.